BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32055786)

  • 1. Ten-eleven translocation-2 affects the fate of cells and has therapeutic potential in digestive tumors.
    Wang F; Zhang J; Qi J
    Chronic Dis Transl Med; 2019 Dec; 5(4):267-272. PubMed ID: 32055786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tet2 Catalyzes Stepwise 5-Methylcytosine Oxidation by an Iterative and de novo Mechanism.
    Crawford DJ; Liu MY; Nabel CS; Cao XJ; Garcia BA; Kohli RM
    J Am Chem Soc; 2016 Jan; 138(3):730-3. PubMed ID: 26734843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?
    Ma C; Seong H; Liu Y; Yu X; Xu S; Li Y
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):895-915. PubMed ID: 34719214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance DNA Methyltransferase Activity in the Presence of Oxidized Forms of 5-Methylcytosine: Structural Basis for Ten Eleven Translocation-Mediated DNA Demethylation.
    Seiler CL; Fernandez J; Koerperich Z; Andersen MP; Kotandeniya D; Nguyen ME; Sham YY; Tretyakova NY
    Biochemistry; 2018 Oct; 57(42):6061-6069. PubMed ID: 30230311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations along a TET2 active site scaffold stall oxidation at 5-hydroxymethylcytosine.
    Liu MY; Torabifard H; Crawford DJ; DeNizio JE; Cao XJ; Garcia BA; Cisneros GA; Kohli RM
    Nat Chem Biol; 2017 Feb; 13(2):181-187. PubMed ID: 27918559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells.
    Secardin L; Limia CEG; di Stefano A; Bonamino MH; Saliba J; Kataoka K; Rehen SK; Raslova H; Marty C; Ogawa S; Vainchenker W; Monte-Mor BDCR; Plo I
    Stem Cell Res; 2020 Apr; 44():101755. PubMed ID: 32193150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation.
    Ruiz MA; Rivers A; Ibanez V; Vaitkus K; Mahmud N; DeSimone J; Lavelle D
    Epigenetics; 2015; 10(5):397-407. PubMed ID: 25932923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET proteins and the control of cytosine demethylation in cancer.
    Scourzic L; Mouly E; Bernard OA
    Genome Med; 2015; 7(1):9. PubMed ID: 25632305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate quantification of 5-Methylcytosine, 5-Hydroxymethylcytosine, 5-Formylcytosine, and 5-Carboxylcytosine in genomic DNA from breast cancer by chemical derivatization coupled with ultra performance liquid chromatography- electrospray quadrupole time of flight mass spectrometry analysis.
    Guo M; Li X; Zhang L; Liu D; Du W; Yin D; Lyu N; Zhao G; Guo C; Tang D
    Oncotarget; 2017 Oct; 8(53):91248-91257. PubMed ID: 29207640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and determination of the oxidation products of 5-methylcytosine in RNA.
    Huang W; Lan MD; Qi CB; Zheng SJ; Wei SZ; Yuan BF; Feng YQ
    Chem Sci; 2016 Aug; 7(8):5495-5502. PubMed ID: 30034689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tet2-mediated DNA demethylation regulates the proliferation and apoptosis of human leukemia K562 cells.
    Qiao Y; Zhou Y; Yang H; He Z; Fan A
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):23-27. PubMed ID: 37300692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TET Family of Dioxygenases: Crucial Roles and Underlying Mechanisms.
    Li D; Guo B; Wu H; Tan L; Lu Q
    Cytogenet Genome Res; 2015; 146(3):171-80. PubMed ID: 26302812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma.
    Shi X; Yu Y; Luo M; Zhang Z; Shi S; Feng X; Chen Z; He J
    PLoS One; 2016; 11(4):e0153100. PubMed ID: 27050164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive and simultaneous determination of 5-methylcytosine and its oxidation products in genomic DNA by chemical derivatization coupled with liquid chromatography-tandem mass spectrometry analysis.
    Tang Y; Zheng SJ; Qi CB; Feng YQ; Yuan BF
    Anal Chem; 2015 Mar; 87(6):3445-52. PubMed ID: 25675106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive/negative ion-switching-based LC-MS/MS method for quantification of cytosine derivatives produced by the TET-family 5-methylcytosine dioxygenases.
    Dey AS; Ayon NJ; Bhattacharya C; Gutheil WG; Mukherji M
    Biol Methods Protoc; 2020; 5(1):bpaa019. PubMed ID: 33376805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine.
    Cadet J; Wagner JR
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Apr; 764-765():18-35. PubMed ID: 24045206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tet proteins: on track towards DNA demethylation?
    Véron N
    Biomol Concepts; 2012 Oct; 3(5):395-402. PubMed ID: 25436545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of
    Wang B; Xia M; Chen T; Li M; Shi D; Wang X; Pang A; Zhou J; Yuan W; Chu Y
    Blood Sci; 2020 Oct; 2(4):129-136. PubMed ID: 35400021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis.
    Chen Z; Shi X; Guo L; Li Y; Luo M; He J
    Oncotarget; 2017 Jan; 8(1):1944-1952. PubMed ID: 27911867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Tet-mediated oxidation products of 5-methylcytosine on DNA transcription in vitro and in mammalian cells.
    You C; Ji D; Dai X; Wang Y
    Sci Rep; 2014 Nov; 4():7052. PubMed ID: 25394478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.